Nimodipine (NM) tablets with high dissolution containing NM solid dispersions prepared by hot-melt extrusion

References

• Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413–420.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47–60.
   PubMed Web of Science ®Google Scholar
• Forster A, Rades T, Hempenstall J. (2002). Selection of suitable drug and excipient candidates to prepare glass solutions by melt extrusion for immediate release oral formulations. Pharm Technol Eur, 14:27–37.
   Google Scholar
• Chokshi RJ, Sandhu HK, Iyer RM, Shah NH, Malick AW, Zia H. (2005). Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion process as a means to manufacture solid dispersion/solution. J Pharm Sci, 94:2463–2474.
   PubMed Web of Science ®Google Scholar
• Van den Mooter G, Wuyts M, Blaton N, Busson R, Grobet P, Augustijns P et al. (2001). Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci, 12:261–269.
   PubMed Web of Science ®Google Scholar
• Breitenbach, J. (2003). Pharmaceutical Extrusion Technology. Marcel Dekker: New York.
   Google Scholar
• Crowley MM, Zhang F, Repka MA, Thumma S, Upadhye SB, Battu SK et al. (2007). Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm, 33:909–926.
   PubMed Web of Science ®Google Scholar
• He H, Yang R, Tang X. (2010). In vitro and in vivo evaluation of fenofibrate solid dispersion prepared by hot-melt extrusion. Drug Dev Ind Pharm, 36:681–687.
   PubMed Web of Science ®Google Scholar
• Patterson JE, James MB, Forster AH, Rades T. (2008). Melt extrusion and spray drying of carbamazepine and dipyridamole with polyvinylpyrrolidone/vinyl acetate copolymers. Drug Dev Ind Pharm, 34:95–106.
   PubMed Web of Science ®Google Scholar
• Repka MA, Battu SK, Upadhye SB, Thumma S, Crowley MM, Zhang F et al. (2007). Pharmaceutical applications of hot-melt extrusion: Part II. Drug Dev Ind Pharm, 33:1043–1057.
   PubMed Web of Science ®Google Scholar
• Trey SM, Wicks DA, Mididoddi PK, Repka MA. (2007). Delivery of itraconazole from extruded HPC films. Drug Dev Ind Pharm, 33:727–735.
   PubMed Web of Science ®Google Scholar
• Yang R, Wang Y, Zheng X, Meng J, Tang X, Zhang X. (2008). Preparation and evaluation of ketoprofen hot-melt extruded enteric and sustained-release tablets. Drug Dev Ind Pharm, 34:83–89.
   PubMed Web of Science ®Google Scholar
• Hoftyzer PJ, Krevelen DWV. (1976). Properties of Polymers. Elsevier: Amsterdam.
   Google Scholar
• Qi S, Gryczke A, Belton P, Craig DQ. (2008). Characterisation of solid dispersions of paracetamol and EUDRAGIT E prepared by hot-melt extrusion using thermal, microthermal and spectroscopic analysis. Int J Pharm, 354:158–167.
   PubMed Web of Science ®Google Scholar
• China Pharmacopeia, Beijing, 2005, pp. 166-167.
   Google Scholar
• Greenhalgh DJ, Williams AC, Timmins P, York P. (1999). Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci, 88:1182–1190.
   PubMed Web of Science ®Google Scholar
• Goddeeris C, Willems T, Houthoofd K, Martens JA, Van den Mooter G. (2008). Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100. Eur J Pharm Biopharm, 70:861–868.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Zografi G. (1999). Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res, 16:1722–1728.
   PubMed Web of Science ®Google Scholar
• Roos YH. (1997). Frozen state transitions in relation to freeze drying. J Thermal Anal, 48:535–544.
   Web of Science ®Google Scholar
• Zheng X, Yang R, Tang X, Zheng L. (2007). Part I: characterization of solid dispersions of nimodipine prepared by hot-melt extrusion. Drug Dev Ind Pharm, 33:791–802.
   PubMed Web of Science ®Google Scholar
• Hancock BC, Zografi G. (1997). Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci, 86:1–12.
   PubMed Web of Science ®Google Scholar
• Weuts I, Kempen D, Decorte A, Verreck G, Peeters J, Brewster M et al. (2004). Phase behaviour analysis of solid dispersions of loperamide and two structurally related compounds with the polymers PVP-K30 and PVP-VA64. Eur J Pharm Sci, 22:375–385.
   PubMed Web of Science ®Google Scholar
• Sun Y, Rui Y, Wenliang Z, Tang X. (2008). Nimodipine semi-solid capsules containing solid dispersion for improving dissolution. Int J Pharm, 359:144–149.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Sunada H. (1998). Comparison of nicotinamide, ethylurea and polyethylene glycol as carriers for nifedipine solid dispersions systems. Chem Pharm Bull, 46:482–487.
   PubMed Web of Science ®Google Scholar
• Damian F, Blaton N, Kinget R, Van den Mooter G. (2002). Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30. Int J Pharm, 244:87–98.
   PubMed Web of Science ®Google Scholar
• Weuts I, Kempen D, Decorte A, Verreck G, Peeters J, Brewster M et al. (2005). Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64. Eur J Pharm Sci, 25:313–320.
   PubMed Web of Science ®Google Scholar
• Fu J-J, Zhang L-L, Guan T-T, Tang X, He H-B. (2010). Stable nimodipine tablets with high availability containing NM-SD prepared by hot-melt extrusion. Powder Technol, 204:214–221.
   Web of Science ®Google Scholar